IGF2 and familial hyperaldosteronism: Anaplasia has been commonly associated with TP53 loss [58], while mutations in WT1 and epigenetic changes—particularly loss of imprinting (LOI)—at the Insulin-like Growth Factor II (IGF2)/H19 locus have been associated with FH [59].